A Journey Into Participation Patterns Among Patients With Hidradenitis Suppurativa

Part of paid clinical trials in San Francisco, California.

Sponsor
Power Life Sciences Inc.
Study ID
NCT06201858
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This study aims to uncover the factors driving patient decisions regarding enrollment, withdrawal, or re-engagement in hidradenitis suppurativa clinical trials. Understanding these factors will significantly improve the relevance and effectiveness of future research endeavors. Ultimately, this trial endeavors to deepen our understanding of the factors impacting hidradenitis suppurativa clinical trial participation. Enhancing participation rates could accelerate the development of innovative treatments for this debilitating condition.

Key Dates

Start date
Jan 31, 2025
Status verified
Feb 2024
Primary completion
Jan 31, 2026
Completion
Jan 31, 2027

Study Design

Enrollment
500 participants (estimated)

Primary Outcome Measure

Number of hidradenitis suppurativa patients who decide to enroll in a clinical research [ Time Frame: 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Power Life SciencesSan FranciscoCalifornia94107
Michael B Gill
https://www.withpower.com/[email protected]
415-900-4227

Find similar trials in San Francisco, CA

By condition
Hidradenitis suppurativa
By specialty
DermatologyRheumatologyAutoimmune disease
By research site
Power Life Sciences· San Francisco, CA

Related Studies